twenty-one patients with cerebral arteriosclerosis were treated for twelve months with placebo or cyclandelate ( cyclospasmol ) , 400 mg four times daily , in a double-blind study with medication cross-over after six months .
C0010525
cyclandelate
C0795734
cyclospasmol